18:43 , May 22, 2019 |  BC Extra  |  Company News

AlloVir, first to test ElevateBio's model, raises $120M ahead of Phase III

The first disclosed company that will test newly launched ElevateBio's cell and gene therapy model is antiviral treatment developer AlloVir, which revealed the companies' relationship along with a $120 million series B round on Wednesday....
07:00 , Apr 14, 2016 |  BC Innovations  |  Strategy

Next stop: Houston

Last month's opening by Johnson & Johnson of the Houston-based JLABS incubator is being seen as a coup by local leaders hoping to make the city the "third coast" of biotech. But stakeholders inside and...